Trump meets Novartis CEO, says drugmaker building 11 US plants

Group 1 - Novartis is building 11 manufacturing plants in the U.S. as a result of U.S. President Trump's tariff policies [1] - The company plans to expand its radioligand therapy manufacturing network with a new site in Florida [1] - Last year, Novartis announced a $23 billion investment to build and expand 10 facilities in the U.S. following threats of drug import duties from the Trump administration [1]